{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:49:43Z","timestamp":1785473383634,"version":"3.56.0"},"reference-count":66,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1111\/jcpt.13449","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T06:51:47Z","timestamp":1624431107000},"page":"1531-1548","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Methodological quality of guidelines for the management of opioid use disorder: A systematic review"],"prefix":"10.1155","volume":"46","author":[{"given":"Abuzar","family":"Watan Pal","sequence":"first","affiliation":[{"name":"Faculty of Medicine University Malaya  Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7113-9323","authenticated-orcid":false,"given":"Zoriah","family":"Aziz","sequence":"additional","affiliation":[{"name":"Faculty of Medicine University Malaya  Kuala Lumpur Malaysia"},{"name":"Faculty of Pharmacy MAHSA University  Jenjarom Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeeba","family":"Kamarulzaman","sequence":"additional","affiliation":[{"name":"Faculty of Medicine University Malaya  Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.9422216.x"},{"key":"e_1_2_7_4_1","unstructured":"World Health Organization.Opioid Overdose factsheet;2020.https:\/\/www.who.int\/news\u2010room\/fact\u2010sheets\/detail\/opioid\u2010overdose. Accessed March 14 2021."},{"key":"e_1_2_7_5_1","unstructured":"United Nations Office on Drugs and Crime.World Drug Report 2012.https:\/\/www.unodc.org\/documents\/data\u2010and\u2010analysis\/WDR2012\/WDR_2012_web_small.pdf. Accessed March 14 2021."},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12088"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1604339"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.09.013"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4603(02)00297-6"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.20.1900"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/qshc.2010.042077"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181927"},{"key":"e_1_2_7_13_1","first-page":"1","article-title":"Quality related problems in clinical practice guidelines","volume":"20","author":"Gaminde I","year":"2012","journal-title":"Drug Ther Bull"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v21n03_01"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.7.850"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1992.00400170036007"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviscsurg.2010.10.010"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.188"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.14.1775"},{"key":"e_1_2_7_20_1","unstructured":"Canadian Agency for Drugs and Technologies in Health CADTH.Treatment for Opioid Dependence: A Review of Guidelines;2012.https:\/\/cadth.ca\/media\/pdf\/htis\/sept\u20102012\/RC0390%20Opioid%20Dependency%20Guidelines%20Final.pdf. Accessed September 14 2019."},{"key":"e_1_2_7_21_1","volume-title":"Treatment Programs for Opioid Use Disorders: A Review of Guidelines","author":"Gray C","year":"2018"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100"},{"key":"e_1_2_7_23_1","unstructured":"Strings attached: CADTH database search filters: guidelines\u2010 PubMed.Ottawa:CADTH;2019.https:\/\/www.cadth.ca\/resources\/finding\u2010evidence\/strings\u2010attached\u2010cadths\u2010database\u2010search\u2010filters#guide"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090449"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzi027"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174831"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.12.009"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-2744"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000166"},{"key":"e_1_2_7_30_1","unstructured":"Substance Abuse and Mental Health Services Administration.Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants. HHS Publication No. (SMA) 18\u20105054.Rockville MD;2018.https:\/\/www.drugsandalcohol.ie\/28957\/1\/Samsha_Clinical_guidance_for_treating\u2010pregnant_and_parenting_women\u2010with\u2010opioid.pdf. Accessed September 29 2019."},{"key":"e_1_2_7_31_1","unstructured":"WallerRC.Medication Assisted Treatment Guidelines for Opioid Use Disorders.Michigan Department of Community Health State of Michigan;2014.http:\/\/indianacouncil.org\/sites\/default\/files\/resources\/Dr.%20Waller.pdf. Accessed October 20 2019."},{"key":"e_1_2_7_32_1","unstructured":"BerryP BesioS BrooklynJR et al.Vermont buprenorphine practice guidelines.Vermont Department of Health Division of Alcohol and Drug Abuse Department of Vermont Health Access;2003.http:\/\/contentmanager.med.uvm.edu\/docs\/default\u2010source\/vchip\u2010documents\/vchip_2buprenorphine_guidelines.pdf?sfvrsn=2. Accessed December 2019"},{"key":"e_1_2_7_33_1","volume-title":"Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction","author":"Center for Substance Abuse Treatment","year":"2004"},{"key":"e_1_2_7_34_1","volume-title":"Buprenorphine: A Guide for Nurses","author":"Center for Substance Abuse Treatment","year":"2009"},{"key":"e_1_2_7_35_1","unstructured":"StephensonD LingW VastiE et al.Guideline for physicians working in California opioid treatment programs.California Society of Addiction Medicine CSAM Committee on Treatment of Opioid Dependence (US);2009. https:\/\/cdn.ymaws.com\/csam\u2010asam.org\/resource\/collection\/0BE82575\u2010F893\u20104CF6\u20108954\u2010B2CAF524DCFE\/CSAM\u2010guidelines.pdf. Accessed July 2019"},{"issue":"4","key":"e_1_2_7_36_1","first-page":"5","article-title":"Treatment of patients with substance use disorders, second edition","volume":"164","author":"Kleber HD","year":"2007","journal-title":"Am J Psychiatry"},{"key":"e_1_2_7_37_1","unstructured":"Substance Abuse and Mental Health Services Administration.Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63. HHS Publication No (SMA) 10\u20105063.Rockville MD;2018.https:\/\/medicine.yale.edu\/edbup\/resources\/TIP_63_338482_284_42920_v1.pdf. Accessed October 23 2019."},{"key":"e_1_2_7_38_1","unstructured":"The Management of Substance Use Disorders Work Group. VA\/DoD Clinical Practice Guidelines for the Management of Substance Use Disorders.Department of Veteran Affairs\/Department of Defense (US);2015.https:\/\/www.healthquality.va.gov\/guidelines\/MH\/sud\/VADODSUDCPGRevised22216.pdf. Accessed November 15 2019"},{"key":"e_1_2_7_39_1","unstructured":"HandfordC KahanM Srivastava A et al.Buprenorphine\/Naloxone for Opioid Dependence: Clinical Practice Guideline.Centre for Addiction and Mental Health (Canada);2012.https:\/\/www.drugsandalcohol.ie\/16240\/1\/CAMH_Buprenorphine_Naloxone.pdf. Accessed December 25 2019"},{"key":"e_1_2_7_40_1","unstructured":"AdamsE Badenhorst C SkuridinaN et al. AGuideline for the Clinical Management of Opioid Use Disorder.British Columbia Centre on Substance Use and B.C. Ministry of Health.2017.https:\/\/www.bccsu.ca\/wp\u2010content\/uploads\/2017\/06\/BC\u2010OUD\u2010Guidelines_June2017.pdf. Accessed December 28 2019."},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170958"},{"issue":"5","key":"e_1_2_7_42_1","first-page":"321","article-title":"Managing opioid use disorder in primary care: PEER simplified guideline","volume":"65","author":"Korownyk C","year":"2019","journal-title":"Can Fam Physician"},{"key":"e_1_2_7_43_1","volume-title":"Methadone Maintenance Treatment Program Standards and Clinical Guidelines","author":"Smith C","year":"2011"},{"key":"e_1_2_7_44_1","volume-title":"Guidance for the Use of Substitute Prescribing in the Treatment of Opioid Dependence in Primary Care","author":"Ford C","year":"2011"},{"key":"e_1_2_7_45_1","volume-title":"Drug Misuse and Dependence: UK guidelines on clinical management","author":"Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working Group","year":"2017"},{"key":"e_1_2_7_46_1","series-title":"Technology appraisal GUIDANCE No. 114","volume-title":"Methadone and Buprenorphine for the Management of Opioid Dependence","author":"National Institute for Health and Care Excellence","year":"2007"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112444324"},{"key":"e_1_2_7_48_1","series-title":"Clinical Guideline No. CG51","volume-title":"Drug Misuse in Over 16s: Psychosocial Interventions","author":"National Institute for Health and Care Excellence","year":"2007"},{"key":"e_1_2_7_49_1","series-title":"Clinical Guideline CG No. 52","volume-title":"Drug Misuse in Over 16s: Opioid Detoxification","author":"National Institute for Health and Care Excellence","year":"2007"},{"key":"e_1_2_7_50_1","volume-title":"Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence","author":"WHO","year":"2009"},{"key":"e_1_2_7_51_1","volume-title":"Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy","author":"WHO","year":"2014"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2011.561872"},{"key":"e_1_2_7_53_1","volume-title":"National Guidelines for Medication\u2010Assisted Treatment of Opioid Dependence","author":"Gowing L","year":"2014"},{"key":"e_1_2_7_54_1","volume-title":"New Zealand Practice Guidelines for Opioid Substitution Treatment","author":"Ministry of Health","year":"2014"},{"issue":"1","key":"e_1_2_7_55_1","first-page":"1","article-title":"South African guidelines for the management of opioid dependence: updated 2009","volume":"100","author":"Weich L","year":"2010","journal-title":"S Afr Med J"},{"key":"e_1_2_7_56_1","first-page":"A726","article-title":"Richtlijn 'Medicamenteuze zorg aan gedetineerde verslaafden' [Guideline 'Medicinal care for drug addicts in penal institutions']","volume":"153","author":"Westra M","year":"2009","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs5.17"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.06.157"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1177\/0141076813486261"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.05.018"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-7-62"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025153"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082915"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1136\/oemed-2013-101656"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-014-3530-0"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082986"},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.3109\/14647273.2013.872301"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcpt.13449","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jcpt.13449","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcpt.13449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:06:35Z","timestamp":1671818795000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.13449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1111\/jcpt.13449"],"URL":"https:\/\/doi.org\/10.1111\/jcpt.13449","archive":["Portico"],"relation":{},"ISSN":["0269-4727","1365-2710"],"issn-type":[{"value":"0269-4727","type":"print"},{"value":"1365-2710","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"assertion":[{"value":"2021-03-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}